<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01815645</url>
  </required_header>
  <id_info>
    <org_study_id>2011/01469-7 (FAPESP)</org_study_id>
    <nct_id>NCT01815645</nct_id>
  </id_info>
  <brief_title>Contingency Management Treatment for Crack Addiction - Study With Brazilian Population</brief_title>
  <official_title>Evaluating the Efficacy of Including Contingency Management to Standard Ambulatory Treatment for Crack Addiction - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crack addiction has become a severe health problem in Brazil. Today, crack addiction is the
      primary cause for inpatient treatment for all illicit substances. When compared to cocaine,
      crack users develop much faster diagnoses for crack dependence, shows a more compulsive
      pattern of use, has higher probability of living or have lived in the streets, and of
      engaging in illegal activities. Consequently to this, mortality of crack addicts is 7 times
      higher than for the rest of the population.

      Despite all efforts being made for the development of effective pharmacological treatments
      for stimulant addiction (crack included), up to today, there is no robust evidence of
      efficacy of any pharmacological treatment. For that reason, the use of evidence based
      psychosocial interventions is so important for treating this population.

      Although today open treatment facilities in Brazil are more and more starting to use
      evidence-based interventions such as motivational interviewing, cognitive behavior therapy,
      relapse prevention and coping skills, such treatments present very modest results when
      treating crack addiction. The biggest difficulties encountered when treating this population
      are maintaining patients in treatment, reducing crack use and achieving continued abstinence.

      A psychosocial treatment based in behavioral principals' named Contingency Management (CM) is
      widely applied in the USA. Recent meta-analyses and review studies present robust evidence
      that, when applied alone or in adjunction with other psychosocial and pharmacological
      treatment, CM is the most effective treatment for what regards, treatment retention, reducing
      drug use and promoting continued abstinence.

      The purpose of this study is to evaluate if Contingence Management (CM) can be affective in
      the treatment of crack addiction in Brazil. To accomplish this, 60 individuals (male and
      female from 18 to 65 years of age) seeking open treatment for crack addiction will be
      randomized to 2 treatment conditions (Standard treatment (ST) or ST+CM. Both treatments will
      last 12 weeks with 3 and 6-month follow-up. In both groups patients will be encourage to
      leave urine samples 3 times week.

      Hypotheses: Patients receiving ST+CM will stay longer in treatment, have more negative tests
      for cocaine/crack, and achieve longer periods of cocaine/crack abstinence when compared to
      patients receiving ST alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a Randomized Clinical Trial deigned to investigate the effects of including
      Contingency Management to a standard public ambulatory treatment in Brazil on treatment
      attendance, retention in treatment, reduction of crack cocaine use and promotion of crack
      cocaine abstinence for crack dependent individuals seeking treatment for there addiction. In
      total 65 subjects will be randomized to receive Standard Treatment Alone or Standard
      Treatment plus Contingency Management. Both interventions will last for 12 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Both participants and researchers know the treatment alocations</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Longest Duaration of Achieved Abstinance</measure>
    <time_frame>12 weeks of treatment</time_frame>
    <description>Number of Participants with 4, 8 and 12 Weeks Continued Abstinence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage Samples Submitted Negative for Crack Cocaine Use</measure>
    <time_frame>12 weeks</time_frame>
    <description>Proportion of samples testing negative for Crack Cocaine use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Completing 4, 8 and 12 Weeks of Treatment</measure>
    <time_frame>Number of participant retained in treatment at weeks 4, 8 and 12.</time_frame>
    <description>Retention in treatment was quantified as the period elapsed between treatment intake and dropout (last appearance at the treatment facility) or the end of treatment. We present data on the number of participants retained in treatment in weeks 4, 8 and 12.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Attendance</measure>
    <time_frame>12 weeks</time_frame>
    <description>Treatment attendance was expressed as the total number of sessions attended during the 12 weeks of treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage Samples Submitted Negative for Alcohol Use</measure>
    <time_frame>12 weeks</time_frame>
    <description>Proportion of samples testing negative for alcohol use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage Samples Submitted Negative for Marihuana Use</measure>
    <time_frame>12 weeks</time_frame>
    <description>The proportion of samples testing negative for marijuana was determined by dividing the number of negative samples by the total number of expected samples (36 samples)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Cocaine Related Disorders</condition>
  <arm_group>
    <arm_group_label>Standard treatment Alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the Standard Treatment Alone group will receive 12 weeks of the exact treatment provided by the Ambulatory service where the study is being conducted</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ST+CM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the Standard treatment plus Contingency Management (ST+CM) group will receive 12 weeks of the exact treatment provided by the Ambulatory service where the study is being conducted plus CM.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ST+CM</intervention_name>
    <description>12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
    <arm_group_label>ST+CM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>standard treatment</intervention_name>
    <description>12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
    <arm_group_label>Standard treatment Alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Current diagnose of crack addiction (DSM IV)

          -  having used crack in the last month

        Exclusion Criteria:

          -  Current psychotic disorder

          -  Diagnose of schizophrenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronaldo R Laranjeira, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EPM/UNIFESP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ambulatorio Medico de Especialidades (AME) da Vila Maria</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Miguel AQ, Madruga CS, Cogo-Moreira H, Yamauchi R, Simões V, da Silva CJ, McPherson S, Roll JM, Laranjeira RR. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial. Psychol Addict Behav. 2016 Aug;30(5):536-543. Epub 2016 Jul 21.</citation>
    <PMID>27442691</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2013</study_first_submitted>
  <study_first_submitted_qc>March 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2013</study_first_posted>
  <results_first_submitted>August 10, 2015</results_first_submitted>
  <results_first_submitted_qc>April 4, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 19, 2017</results_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>André de Queiroz Constantino Miguel</investigator_full_name>
    <investigator_title>Ph.D Studant</investigator_title>
  </responsible_party>
  <keyword>Cocaine related disorders</keyword>
  <keyword>Contingency Management</keyword>
  <keyword>psychosocial treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Treatment</title>
          <description>standard treatment: 32 participants received 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
        </group>
        <group group_id="P2">
          <title>Standard Treatment Plus Contingency Management</title>
          <description>33 participants received Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Treatment</title>
          <description>standard treatment: 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
        </group>
        <group group_id="B2">
          <title>Standard Treatment Plus Contingency Management</title>
          <description>Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="65"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.4" spread="8.5"/>
                    <measurement group_id="B2" value="35.3" spread="8.7"/>
                    <measurement group_id="B3" value="35.3" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Longest Duaration of Achieved Abstinance</title>
        <description>Number of Participants with 4, 8 and 12 Weeks Continued Abstinence</description>
        <time_frame>12 weeks of treatment</time_frame>
        <population>Longest duaration of abstinance was determined by the highest amount of consecutive negative crack/cocaine samples submitted.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>standard treatment: 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
          </group>
          <group group_id="O2">
            <title>Standard Treatment Plus Contingency Management</title>
            <description>Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
          </group>
        </group_list>
        <measure>
          <title>Longest Duaration of Achieved Abstinance</title>
          <description>Number of Participants with 4, 8 and 12 Weeks Continued Abstinence</description>
          <population>Longest duaration of abstinance was determined by the highest amount of consecutive negative crack/cocaine samples submitted.</population>
          <units>number of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 weeks of abstinance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 weeks of abstinance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks of abstinance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage Samples Submitted Negative for Crack Cocaine Use</title>
        <description>Proportion of samples testing negative for Crack Cocaine use</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>standard treatment: 32 participants received 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
          </group>
          <group group_id="O2">
            <title>Standard Treatment Plus Contingency Management</title>
            <description>33 participants received Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Samples Submitted Negative for Crack Cocaine Use</title>
          <description>Proportion of samples testing negative for Crack Cocaine use</description>
          <units>percentage of submitted negative samples</units>
          <param>Number</param>
          <units_analyzed>urine samples</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>urine samples</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="113"/>
                <count group_id="O2" value="628"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3"/>
                    <measurement group_id="O2" value="46.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Completing 4, 8 and 12 Weeks of Treatment</title>
        <description>Retention in treatment was quantified as the period elapsed between treatment intake and dropout (last appearance at the treatment facility) or the end of treatment. We present data on the number of participants retained in treatment in weeks 4, 8 and 12.</description>
        <time_frame>Number of participant retained in treatment at weeks 4, 8 and 12.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>standard treatment: 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
          </group>
          <group group_id="O2">
            <title>Standard Treatment Plus Contingency Management</title>
            <description>Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Completing 4, 8 and 12 Weeks of Treatment</title>
          <description>Retention in treatment was quantified as the period elapsed between treatment intake and dropout (last appearance at the treatment facility) or the end of treatment. We present data on the number of participants retained in treatment in weeks 4, 8 and 12.</description>
          <units>number of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Retained in week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retained in week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retained in week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Treatment Attendance</title>
        <description>Treatment attendance was expressed as the total number of sessions attended during the 12 weeks of treatment.</description>
        <time_frame>12 weeks</time_frame>
        <population>we compared group means for the total number of attended sessions.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>standard treatment: 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
          </group>
          <group group_id="O2">
            <title>Standard Treatment Plus Contingency Management</title>
            <description>Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Attendance</title>
          <description>Treatment attendance was expressed as the total number of sessions attended during the 12 weeks of treatment.</description>
          <population>we compared group means for the total number of attended sessions.</population>
          <units>attended treatment sessions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="5.9"/>
                    <measurement group_id="O2" value="19.5" spread="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage Samples Submitted Negative for Alcohol Use</title>
        <description>Proportion of samples testing negative for alcohol use</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>standard treatment: 32 participants received 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
          </group>
          <group group_id="O2">
            <title>Standard Treatment Plus Contingency Management</title>
            <description>33 participants received Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Samples Submitted Negative for Alcohol Use</title>
          <description>Proportion of samples testing negative for alcohol use</description>
          <units>percent of sample</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4"/>
                    <measurement group_id="O2" value="53.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage Samples Submitted Negative for Marihuana Use</title>
        <description>The proportion of samples testing negative for marijuana was determined by dividing the number of negative samples by the total number of expected samples (36 samples)</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>standard treatment: 32 participants received 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
          </group>
          <group group_id="O2">
            <title>Standard Treatment Plus Contingency Management</title>
            <description>33 participants received Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Samples Submitted Negative for Marihuana Use</title>
          <description>The proportion of samples testing negative for marijuana was determined by dividing the number of negative samples by the total number of expected samples (36 samples)</description>
          <units>percent of sample</units>
          <param>Number</param>
          <units_analyzed>percent of sample</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>percent of sample</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8"/>
                    <measurement group_id="O2" value="50.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Standard Treatment</title>
          <description>standard treatment: 12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)</description>
        </group>
        <group group_id="E2">
          <title>Standard Treatment Plus Contingency Management</title>
          <description>Standard treatment plus Contingence Management: 12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Andre Q. C. Miguel</name_or_title>
      <organization>Federal University of Sao Paulo</organization>
      <phone>005511 965884111</phone>
      <email>aqcmiguel@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

